Indication
Vascular inflammation
2 clinical trials
4 products
1 drug
Clinical trial
Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms: a Double Blind Randomized Controlled TrailStatus: Not yet recruiting, Estimated PCD: 2023-12-31
Product
Dimethyl fumarateDrug
VarlilumabClinical trial
Efficacy and Safety of Comprehensive Treatment in Patients With Inflammation-associated Rapidly-progressive Coronary Artery Disease (IR-CAD): a Self-controlled Cohort StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Product
Immunosuppressive therapyProduct
Supportive therapies